NO990322L - Farmas°ytisk blanding inneholdende en 5HT2c-antagonist og en D2-antagonist - Google Patents

Farmas°ytisk blanding inneholdende en 5HT2c-antagonist og en D2-antagonist

Info

Publication number
NO990322L
NO990322L NO990322A NO990322A NO990322L NO 990322 L NO990322 L NO 990322L NO 990322 A NO990322 A NO 990322A NO 990322 A NO990322 A NO 990322A NO 990322 L NO990322 L NO 990322L
Authority
NO
Norway
Prior art keywords
antagonist
5ht2c
mixture containing
pharmaceutical mixture
compounds
Prior art date
Application number
NO990322A
Other languages
English (en)
Other versions
NO990322D0 (no
Inventor
Thomas Paul Blackburn
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO990322D0 publication Critical patent/NO990322D0/no
Publication of NO990322L publication Critical patent/NO990322L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Det beskrives kombinasjoner av forbindelser som har 5HT2C- og D2-antagonistvirkning, forbindelser som har aktivitet ved de to reseptorene, farmasøytiske blandinger hvori disse inngår, og deres anvendelse ved behandling av schizofreni.
NO990322A 1996-07-26 1999-01-25 Farmas°ytisk blanding inneholdende en 5HT2c-antagonist og en D2-antagonist NO990322L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9615767.2A GB9615767D0 (en) 1996-07-26 1996-07-26 Novel treatment
PCT/EP1997/004159 WO1998004289A2 (en) 1996-07-26 1997-07-22 Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist

Publications (2)

Publication Number Publication Date
NO990322D0 NO990322D0 (no) 1999-01-25
NO990322L true NO990322L (no) 1999-03-24

Family

ID=10797573

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990322A NO990322L (no) 1996-07-26 1999-01-25 Farmas°ytisk blanding inneholdende en 5HT2c-antagonist og en D2-antagonist

Country Status (19)

Country Link
EP (1) EP0936924A2 (no)
JP (1) JP2000516924A (no)
KR (1) KR20000029564A (no)
CN (1) CN1230894A (no)
AR (1) AR008083A1 (no)
AU (1) AU725817B2 (no)
BR (1) BR9710568A (no)
CA (1) CA2261813A1 (no)
CO (1) CO5031292A1 (no)
CZ (1) CZ23799A3 (no)
GB (1) GB9615767D0 (no)
HU (1) HUP9903619A3 (no)
IL (1) IL128219A0 (no)
NO (1) NO990322L (no)
NZ (1) NZ333813A (no)
PL (1) PL331426A1 (no)
TR (1) TR199900140T2 (no)
WO (1) WO1998004289A2 (no)
ZA (1) ZA976593B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612883D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
US6174882B1 (en) 1998-11-23 2001-01-16 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
CA2351718A1 (en) 1998-11-23 2000-06-02 Sepracor Inc. Desmethylolanzapine compositions and methods
WO2000030649A1 (en) * 1998-11-23 2000-06-02 Sepracor Inc. Pharmaceutical compositions containing olanzapine-n-oxide
WO2000054764A2 (en) * 1999-03-18 2000-09-21 Children's Hospital Research Foundation A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications
EP1223939A1 (en) * 1999-05-19 2002-07-24 AstraZeneca AB Method of treating weight gain
WO2005013969A1 (en) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Antipsychotic agent with socializing properties

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500998D0 (sv) * 1995-03-19 1995-03-19 Haakan Wilhelm Wikstroem New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics

Also Published As

Publication number Publication date
ZA976593B (en) 1999-01-25
HUP9903619A2 (hu) 2000-10-28
HUP9903619A3 (en) 2001-03-28
PL331426A1 (en) 1999-07-19
WO1998004289A3 (en) 1998-03-19
KR20000029564A (ko) 2000-05-25
EP0936924A2 (en) 1999-08-25
CN1230894A (zh) 1999-10-06
WO1998004289A2 (en) 1998-02-05
CZ23799A3 (cs) 1999-06-16
CA2261813A1 (en) 1998-02-05
IL128219A0 (en) 1999-11-30
NO990322D0 (no) 1999-01-25
BR9710568A (pt) 1999-08-17
NZ333813A (en) 2000-07-28
GB9615767D0 (en) 1996-09-04
AU4297297A (en) 1998-02-20
CO5031292A1 (es) 2001-04-27
TR199900140T2 (xx) 1999-03-22
JP2000516924A (ja) 2000-12-19
AU725817B2 (en) 2000-10-19
AR008083A1 (es) 1999-12-09

Similar Documents

Publication Publication Date Title
NO20002787L (no) Nye forbindelser
ATE231872T1 (de) Thiazolopyrimidinderivate
TR200101859T2 (tr) Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler
BR9810712A (pt) Processo para a prevenção ou tratamento de prurido em um paciente
NO963506D0 (no) 4-Heterocyklyl-substituerte kinazolin-derivater, fremgangsmåte for fremstilling derav og deres anvendelse som anti-kreftmidler
SE9504661D0 (sv) New compounds
UA66750C2 (en) Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors
AU5624699A (en) Use of 5ht-6 antagonists
ATE302606T1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
TR200100054T2 (tr) Paroksetin metansülfonat
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
NO984290L (no) Farmas°ytisk nyttige forbindelser
NO990322L (no) Farmas°ytisk blanding inneholdende en 5HT2c-antagonist og en D2-antagonist
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
SE9504662D0 (sv) New compounds
NO992298L (no) Konformasjonsbegrensede LH-RH analoger, anvendelse derav og farmas°ytiske sammensetninger inneholdende disse
DK0763535T3 (da) Piperidinylmethyloxazolidin-2-on-derivater, deres fremstilling og deres anvendelse som centralnervesystem-aktive forbindelser
AU580890B2 (en) P-acylaminobenzamides
BR9606955A (pt) Heterocicloalquenos substituísos
BR9812002A (pt) Compostos com efeito antiprimeiro-passe
NO952483D0 (no) Seskviterpener, deres fremstilling og anvendelse som inhibitorer innvirkende på gababenzodiazepinreseptorer
SE9803277D0 (sv) Novel compounds
ATE268768T1 (de) Antithrombosemittel
ITMI922216A1 (it) Nitrobenzoilalanine, procedimento per la loro preparazione, loro uso come agenti terapeutici e composizioni farmaceutiche che le contengono

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application